tiprankstipranks
Advertisement
Advertisement
QuidelOrtho Balances Near-Term Strain With Recovery Plan
PremiumCompany AnnouncementsQuidelOrtho Balances Near-Term Strain With Recovery Plan
1M ago
QuidelOrtho  reports adjusted Q1 EPS (4c), consensus 42c
Premium
The Fly
QuidelOrtho reports adjusted Q1 EPS (4c), consensus 42c
1M ago
QuidelOrtho sees FY26 adjusted EPS $1.80-$2.00, consensus $2.16
Premium
The Fly
QuidelOrtho sees FY26 adjusted EPS $1.80-$2.00, consensus $2.16
1M ago
Midday Fly By: PepsiCo reports mixed Q1, TSMC reports Q1 beat
PremiumThe FlyMidday Fly By: PepsiCo reports mixed Q1, TSMC reports Q1 beat
2M ago
Morning Movers: Hims & Hers jumps as FDA looks to broader peptide access
Premium
The Fly
Morning Movers: Hims & Hers jumps as FDA looks to broader peptide access
2M ago
Video: PepsiCo rises as sales and earnings beat expectations
Premium
The Fly
Video: PepsiCo rises as sales and earnings beat expectations
2M ago
QuidelOrtho price target lowered to $17 from $30 at UBS
PremiumThe FlyQuidelOrtho price target lowered to $17 from $30 at UBS
2M ago
QuidelOrtho Announces Chief Legal Officer Leadership Transition
Premium
Company Announcements
QuidelOrtho Announces Chief Legal Officer Leadership Transition
3M ago
QuidelOrtho names Nathaniel Sisitsky as Chief Legal Officer
Premium
The Fly
QuidelOrtho names Nathaniel Sisitsky as Chief Legal Officer
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100